AAAAAA

   
Results: 1-19 |
Results: 19
Kenneth M. Brinkhous: Investigator, teacher, administrator, and gene therapist
Authors: White, GC Roberts, HR
Citation: Gc. White et Hr. Roberts, Kenneth M. Brinkhous: Investigator, teacher, administrator, and gene therapist, MOL THER, 3(4), 2001, pp. 420-422
Rationale for the use of high dose rFVIIa in a high-titre inhibitor patient with haemophilia B during major orthopaedic procedures
Authors: Cooper, HA Jones, CP Campion, E Roberts, HR Hedner, U
Citation: Ha. Cooper et al., Rationale for the use of high dose rFVIIa in a high-titre inhibitor patient with haemophilia B during major orthopaedic procedures, HAEMOPHILIA, 7(5), 2001, pp. 517-522
Determination of the minimum irradiance required for adequate polymerization of a hybrid and a microfill composite
Authors: Leonard, DL Charlton, DG Roberts, HR Hilton, TJ Zionic, A
Citation: Dl. Leonard et al., Determination of the minimum irradiance required for adequate polymerization of a hybrid and a microfill composite, OPER DENT, 26(2), 2001, pp. 176-180
Kenneth M. Brinkhous - Obituary
Authors: Read, M Nichols, T White, GC Wagner, RH Roberts, HR
Citation: M. Read et al., Kenneth M. Brinkhous - Obituary, THROMB HAEM, 85(4), 2001, pp. X-X
In memoriam: Kenneth M. Brinkhous (1908-2000) - Obituary
Authors: Roberts, HR White, GC Wagner, RH Nichols, TC Read, MS
Citation: Hr. Roberts et al., In memoriam: Kenneth M. Brinkhous (1908-2000) - Obituary, THROMB RES, 102(5), 2001, pp. 385-386
Treatment of bleeding and thrombotic disorders: Introduction
Authors: Roberts, HR
Citation: Hr. Roberts, Treatment of bleeding and thrombotic disorders: Introduction, SEM HEMATOL, 38(4), 2001, pp. 1-1
Recombinant factor VIIa (NovoSeven (R)) and the safety of treatment
Authors: Roberts, HR
Citation: Hr. Roberts, Recombinant factor VIIa (NovoSeven (R)) and the safety of treatment, SEM HEMATOL, 38(4), 2001, pp. 48-50
The dysfibrinogenaemias
Authors: Roberts, HR Stinchcombe, TE Gabriel, DA
Citation: Hr. Roberts et al., The dysfibrinogenaemias, BR J HAEM, 114(2), 2001, pp. 249-257
High-dose factor VIIa increases initial thrombin generation and mediates faster platelet activation in thrombocytopenia-like conditions in a cell-based model system
Authors: Kjalke, M Ezban, M Monroe, DM Hoffman, M Roberts, HR Hedner, U
Citation: M. Kjalke et al., High-dose factor VIIa increases initial thrombin generation and mediates faster platelet activation in thrombocytopenia-like conditions in a cell-based model system, BR J HAEM, 114(1), 2001, pp. 114-120
Gene therapy for hemophilia: A step closer to reality
Authors: White, GC Roberts, HR
Citation: Gc. White et Hr. Roberts, Gene therapy for hemophilia: A step closer to reality, MOL THER, 1(3), 2000, pp. 207-208
The effect of factor X level on thrombin generation and the procoagulant effect of activated factor VII in a cell-based model of coagulation
Authors: Allen, GA Monroe, DM Roberts, HR Hoffman, M
Citation: Ga. Allen et al., The effect of factor X level on thrombin generation and the procoagulant effect of activated factor VII in a cell-based model of coagulation, BL COAG FIB, 11, 2000, pp. S3-S7
The factor VII-Platelet interplay: Effectiveness of recombinant factor VIIa in the treatment of bleeding in severe thrombocytopathia
Authors: Monroe, DM Hoffman, M Allen, GA Roberts, HR
Citation: Dm. Monroe et al., The factor VII-Platelet interplay: Effectiveness of recombinant factor VIIa in the treatment of bleeding in severe thrombocytopathia, SEM THROMB, 26(4), 2000, pp. 373-377
Airflow obstruction in bronchiectasis: correlation between computed tomography features and pulmonary function tests
Authors: Roberts, HR Wells, AU Milne, DG Rubens, MB Kolbe, J Cole, PJ Hansell, DM
Citation: Hr. Roberts et al., Airflow obstruction in bronchiectasis: correlation between computed tomography features and pulmonary function tests, THORAX, 55(3), 2000, pp. 198-204
Deencryption of cellular tissue factor is independent of its cytoplasmic domain
Authors: Wolberg, AS Kon, RH Monroe, DM Ezban, M Roberts, HR Hoffman, M
Citation: As. Wolberg et al., Deencryption of cellular tissue factor is independent of its cytoplasmic domain, BIOC BIOP R, 272(2), 2000, pp. 332-336
Thrombin activates factor XI on activated platelets in the absence of factor XII
Authors: Oliver, JA Monroe, DM Roberts, HR Hoffman, M
Citation: Ja. Oliver et al., Thrombin activates factor XI on activated platelets in the absence of factor XII, ART THROM V, 19(1), 1999, pp. 170-177
Tissue factor de-encryption: ionophore treatment induces changes in tissuefactor activity by phosphatidylserine-dependent and -independent mechanisms
Authors: Wolberg, AS Monroe, DM Roberts, HR Hoffman, MR
Citation: As. Wolberg et al., Tissue factor de-encryption: ionophore treatment induces changes in tissuefactor activity by phosphatidylserine-dependent and -independent mechanisms, BL COAG FIB, 10(4), 1999, pp. 201-210
TFPI beta, a second product from the mouse tissue factor pathway inhibitor(TFPI) gene
Authors: Chang, JY Monroe, DM Oliver, JA Roberts, HR
Citation: Jy. Chang et al., TFPI beta, a second product from the mouse tissue factor pathway inhibitor(TFPI) gene, THROMB HAEM, 81(1), 1999, pp. 45-49
The use of agents that by-pass factor VIII inhibitors in patients with haemophilia
Authors: Roberts, HR
Citation: Hr. Roberts, The use of agents that by-pass factor VIII inhibitors in patients with haemophilia, VOX SANGUIN, 77, 1999, pp. 38-41
A randomized, double-blind comparison of two dosage levels of recombinant factor VIIa in the treatment of joint, muscle and mucocutaneous haemorrhages in persons with haemophilia A and B, with and without inhibitors
Authors: Lusher, JM Roberts, HR Davignon, G Joist, JH Smith, H Shapiro, A Laurian, Y Kasper, CK Mannucci, PM
Citation: Jm. Lusher et al., A randomized, double-blind comparison of two dosage levels of recombinant factor VIIa in the treatment of joint, muscle and mucocutaneous haemorrhages in persons with haemophilia A and B, with and without inhibitors, HAEMOPHILIA, 4(6), 1998, pp. 790-798
Risultati: 1-19 |